4 ms·
That's a fair point, but R&D isn't the only thing encouraging the development of new drugs and technologies. A huge market willing to "overpay" is a massive dri
by twoodfin 13y ago
That's a fair point, but R&D isn't the only thing encouraging the development of new drugs and technologies. A huge market willing to "overpay" is a massive driver. Look at the history of MRI penetration in Canada vs. the U.S. for an oft-used example.
Anecdotally, I've been told of pharmaceuticals that only get cleared for future development because the expected U.S. pricing will make them viable.
- DanBC 13y ago> Anecdotally, I've been told of pharmaceuticals that only get cleared for future development because the expected U.S. pricing will make them viable. That doesn't mean those meds are effective or even not actively harmful. People willing to pay tens of thousands of dollars to gamble on getting an extra 4 weeks of shitty quality life doesn't sound like a good way to run medication development.